Trimtech Therapeutics
Manufacturing · United Kingdom · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Jeffrey Cheah Biomedical Centre Puddicom...Phone Number
+44 1223767800Website
www.trimtechtherapeutics.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About Trimtech Therapeutics
We are creating a differentiated portfolio of potent, highly specific degraders, known as TRIMTACs and TRIMGLUEs, that selectively target the removal of toxic proteins for the treatment of intractable CNS and inflammatory disorders.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Trimtech Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when Trimtech Therapeutics launches new products
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once Trimtech Therapeutics has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on Trimtech Therapeutics recently announced quarterly report
Check out if Trimtech Therapeutics is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at Trimtech Therapeutics
Trimtech Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Check if Trimtech Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Click to see if Trimtech Therapeutics had a recent Job posting/layoffs
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Company Profile Activity
Activity Insights
Trimtech Therapeutics is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Trimtech Therapeutics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Trimtech Therapeutics.
Trimtech Therapeutics financials insights
Gather financial insights about Trimtech Therapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2026
Seed
$47M
Trimtech Therapeutics News & Media
TRIMTECH Therapeutics Brings Total Seed Round to $47M with Additional Investment of ...
CAMBRIDGE, England, June 23, 2026--TRIMTECH Therapeutics (TRIMTECH or the Company), a biotechnology company developing novel small molecule therapies that target and degrade protein aggregates associated with neurodegenerative diseases, today announced it has raised an additional $14 million in seed funding, bringing the total for the round to $47 million (£35 million). The financing was led by Johnson & Johnson’s corporate venture capital organization, Johnson & Johnson Innovation – JJDC, Inc.Top 5 Companies Likely to Transact (Jan 21, 2026) - Dakota
Uncover the top 5 companies poised for transactions in January 2026. Gain insights into potential M&A activity and market impacts.Europe’s biggest seed rounds of Q1 2025: Top tech startups to watch
The Tech.eu Q1 2025 Report reveals that European tech companies raised €18.4 billion across 912 deals during the first quarter of 2025. Approximately 12.7 per cent of these companies successfully clos...
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Trimtech Therapeutics
Sign Up For FreeTo access detailed company insights
We are creating a differentiated portfolio of potent, highly specific degraders, known as TRIMTACs and TRIMGLUEs, that selectively target the removal of toxic proteins for the treatment of intractable CNS and inflammatory disorders.... Read More
